SCHEMBL11878205

SCHEMBL11878205

Cc1ccccc1CN1C2=NC(C)(C)CN2C(=O)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.44
▸ P2RX7 Q99572 5/20 0.43
▸ PTGS1 P23219 1/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ TGM2 P21980 1/20 0.41
▸ TSHR P16473 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ CHRM5 P08912 1/20 0.39
▸ GSK3B P49841 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11881664 0.81 P2RX7 (0.51) P2RX7TSHRHTT
SCHEMBL11871825 0.81 CHRM1 (0.53) P2RX7TSHRHTTALDH1A1CHRM5
SCHEMBL11873522 0.79 TRPA1 (0.40) P2RX7TSHR
SCHEMBL11877099 0.78 P2RX7 (0.53) P2RX7TSHR
SCHEMBL11849441 0.73 TSHR (0.58) TP53P2RX7PTGS1PTGS2TGM2
SCHEMBL15928248 0.71 TGM2 (0.75) PTGS1PTGS2TGM2ALDH1A1MAPT
SCHEMBL10304923 0.69 PTGS1 (0.65) PTGS1PTGS2TGM2TSHRMAPT
SCHEMBL29820186 0.69 PTGS1 (0.65) PTGS1PTGS2TGM2TSHRMAPT
SCHEMBL17147697 0.68 CYP3A4 (0.52) TP53P2RX7PTGS1PTGS2TSHR
SCHEMBL11802291 0.66 CYP3A4 (0.53) TP53P2RX7PTGS1PTGS2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3984556-A Alkyl-substituted-tricyclic quinazolinones for lowering blood pressure SANDOZ, INC. (US) 1976-10-05 — — US disclosed
US-3982000-A Alkyl-substituted-tricyclic quinazolinones as bronchodilators SANDOZ, INC. (US) 1976-09-21 — — US disclosed
Send feedback